ESC Premium Access

The SGLT2 inhibitor era: what more can we expect?

Topic: Diabetes and the Heart
Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance

Congress Presentation

About the speaker

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)
167 presentations

4 more presentations in this session

Welcome and introduction

Speaker: Professor T. Luscher (London, GB)


The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes

Speaker: Professor S. Kaul (Los Angeles, US)


Taking the initiative: the cardiologist´s perspective

Speaker: Professor N. Marx (Aachen, DE)


Audience questions and answers, summary and close

Speaker: Professor T. Luscher (London, GB)


Access the full session

SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes

Speakers: Professor S. Anker, Professor T. Luscher, Professor S. Kaul, Professor N. Marx, Professor T. Luscher

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb